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Abstract
Background
Contact investigation is an important strategy for maintaining control of tuberculosis (TB) in
the United States. However, testing and treatment outcomes specifically to foreign-born
populations are poorly understood. We reviewed literature on testing and LTBI identified
during contact investigations in foreign-born populations living in the US.
Methods
We conducted a comprehensive search of peer-reviewed and grey literature using
Cochrane systematic review methods. We included studies with adult and adolescent popu-
lations that were at least 50% foreign-born. Pooled proportions and 95% confidence inter-
vals (CIs) were calculated via inverse-variance weighted meta-analysis, and cumulative
proportions were calculated as products of adjacent step proportions.
Results
We identified 22 studies published between 1997 and 2014 that included at least 50% for-
eign-born participants. From studies of predominantly (>90%) foreign-born populations,
almost all identified contacts were recruited and had valid test results, and 54.8% (95% CI
45.1–62.5%) of contacts with valid test results tested positive. From studies of majority
(50% to 90%) foreign-born populations, 78.4% (95% CI 78.0–78.9%) of identified contacts
were recruited, 92.0% (95% CI 91.6–92.3%) of recruited contacts had valid test results, and
38.5% (95% CI 31.9%-44.2%) of persons with valid results tested positive. These propor-
tions varied by test type in studies of predominantly foreign-born populations. For every
1000 contacts identified in predominantly foreign-born populations, we estimate that 535
(95% CI 438 to 625) will test positive, and 354 (95% CI 244 to 453) will complete LTBI
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Conclusions
Contact investigation is a high yield activity for identifying and treating foreign-born persons
with LTBI, but must be complemented by other tuberculosis control activities in order to
achieve continued progress toward TB elimination.
Introduction
In the United States, the majority of the burden of Mycobacterium tuberculosis infections occur
in persons who were born in other countries. Tuberculosis (TB) infections can be divided into
two types, latent TB infection (LTBI), an asymptomatic, non-communicable state, and TB dis-
ease (also referred to as active TB), which is symptomatic and contagious. TB disease is usually
confined to the lungs, but disseminated and extrapulmonary disease are possible. Foreign-
born persons accounted for approximately two thirds of the 9,557 cases of TB disease reported
in the United States in 2015 [1]. From the 2012 National Health and Nutrition Examination
Survey, 20.5% of the foreign-born participants over age 5 were tuberculin skin test (TST) posi-
tive [2]. A large number of TB cases occur among undocumented immigrants and persons in
temporary visa classes [3, 4]. These undocumented and temporary foreign-born residents may
be poorly integrated into the US medical care system, making them hard-to-reach for targeted
testing and treatment for TB disease and LTBI.
There are currently two types of tests for LTBI. The first is the TST, where purified protein
derivative (PPD) is injected into the forearm, and the injection site is examined 48 to 72 hours
later for signs of an immune reaction. Because infection with other mycobacteria can cause an
immune response to the antigens in PPD, TSTs may cause false positive results in persons
exposed to nontuberculous mycobacteria or who received the Bacillus Calmette-Guerin
(BCG) vaccine, a live virus vaccine of variable effectiveness among adults that is derived from
an attenuated strain of M. bovis. BCG vaccine is not recommended for use in the United States
because of low TB prevalence and false positive TST reactions among persons who received
the vaccine. BCG vaccination is routine in many high TB burden countries, hampering the
specificity of the TST in persons from these countries. The second type of test is the interferon
gamma release assay (IGRA), which is a laboratory test performed on a blood sample. Second
generation IGRA tests use antigens specific to M. tuberculosis and have superior specificity
among BCG vaccinated persons, and by extension, persons born in high-incidence countries
[5]. Neither test can distinguish between LTBI and TB disease; a diagnosis of LTBI requires a
follow-up evaluation which may include symptom evaluation, chest radiographs, and sputum
smears and cultures, to rule out TB disease.
Contact investigation is one of the major strategies used to maintain control of TB in the
United States in which persons with contact to persons with infectious TB (i.e., contacts) are
identified, recruited, tested, and treated for TB disease and LTBI [6]. While the primary goal of
contact investigation is to identify additional cases of TB disease and to prevent TB disease
incidence among contacts due to transmission from the index case, it also identifies persons
who already have TB disease or have LTBI acquired from other index cases. This review seeks
to examine the effectiveness of the continuum of care for TB contact investigations in recruit-
ing, testing for TB infection using TST or IGRA, diagnosing LTBI and active TB among
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persons testing positive, and treating foreign-born adults and adolescents living in the United
States.
Materials and methods
We refer to this study as a “semi-systematic” review because it is an additional analysis of data
derived from our systematic review of studies published between 1986 and 2014 examining the
yield of community-based TB targeted testing and treatment programs in foreign born popula-
tions in the United States [7]. We used Cochrane Collaboration methods in all aspects of that
review [8]. Studies were located using keywords related to tuberculosis, non-US birth, and
occurring in the United States. See supplemental file (S1 File) for a complete description of the
systematic review’s methods. In addition to reports of community-based TB targeted testing
and treatment programs, search strategies captured studies relevant to TB contact investiga-
tion in the US. The current analysis includes all eligible reports of TB contact investigation
identified through our systematic review, and methods used for screening, data extraction and
analysis were identical to those used in the systematic review. The original search was per-
formed on March 30, 2015. We updated the database search using the same databases and key-
words on April 9, 2018.
Eligibility criteria
In the current analysis, we include studies reporting the results of testing contacts of confirmed
infectious TB cases. Testing for TB infection could be done by either TST or IGRA. Studies
were eligible for inclusion if populations were adult or adolescent contacts of TB cases. Eligible
studies reported including at least 50% foreign-born participants or provided sufficient data to
suggest that such proportions were likely. In studies with less than 50% foreign-born partici-
pants overall, we included data from reported subgroups of at least 50% foreign-born partici-
pants. Data were stratified into two analysis groups: studies of contacts that were 50%-90%
foreign-born (“majority foreign-born”; MFB), and studies of contacts that were more than
90% foreign-born (“predominantly foreign born”; PFB). Because the epidemiology of TB dis-
ease and LTBI differs in children and adults, we excluded studies conducted entirely in pediat-
ric populations, but included studies with mixed adult and pediatric populations if children
were a minority of the overall study population. Outputs of interest were eight sequential steps
in the TB testing and treatment continuum of care 1) identification as a contact; 2) recruitment
into the investigation (the contact was located and cooperated with the investigation); 3)
obtaining a valid test result (reading of a TST, or laboratory processing and evaluation of an
IGRA specimen); 4) testing positive for TB infection; 5) being diagnosed with active TB or
LTBI during follow-up of positive test results (this does not include persons diagnosed with
active TB who tested negative or were not tested for LTBI); 6) being offered LTBI treatment; 7)
starting LTBI treatment; and 8) completing LTBI treatment. At a minimum, eligible studies
reported numbers of contacts with valid test results and numbers of contacts that tested posi-
tive for TB infection.
Data extraction and management
Two authors independently extracted data into a standardized, pre-piloted data extraction
spreadsheet. Data extracted included the information included in Tables 1–3, the number of
persons remaining at each step in the care cascade, and basic information about the index case
(S2 File). One author performed a first extraction of all data, and a second author checked the
first author’s work and did a second extraction of all output variables while blinded to the first
author’s extraction.
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Statistical analysis and data synthesis
All data analyses were performed using Stata versions 12 and 14. Proportions of persons pro-
ceeding from one step in the testing and treatment cascade to subsequent steps were calculated
for individual studies. Pooled summary proportions with 95% confidence intervals (CI) were
estimated via inverse-variance weighted random effects meta-analysis. The Freeman-Tukey
double arcsine transformation was used to normalize individual study proportions and ensure
Table 1. Characteristics of TB contact investigations among foreign-born populations in the United States: Predominantly (>90%) foreign-born study
populations.
Study Setting (density) Types of contacts Period Test type
used
Contact countries or regions of
origin (non-USA)
Index case countries
or regions of origin
Number
valid results
Albrecht
2004
California;
Washington (rural)
Social 2003 TST Mexico Mexico 56
Brisette
2011
Harris County,
Texas (urban)
Workplace, school,
residence
2010–2011 IGRA or
TST
Not reported African countries 61
Dewan
2006
San Francisco,
California (urban)
Workplace, school,
residence
2004 TST Mexico and Central American
countries
Not reported, but
not United States
43
Driver
2003
New York City, New
York (urban)
Workplace, school 1995–2000 TST Numerous Numerous 1091
Gulati
2005
Not reported (not
reported)
Workplace 2004 TST Colombia, Ecuador, El Salvador,
Guatemala, Honduras, India,
Mexico, Peru, Poland
El Salvador 36
Ho 2010 San Francisco,
California (urban)
Residence 2006–2007 TST Mexico Mexico 29
Kambali
2014
Texas (rural) Workplace 2011 IGRA Burma, Ethiopia, Haiti, Mexico,
Somalia, Sudan, United States
Iraq 42
Kim 2002 Sussex County,
Delaware (not
reported)
Workplace, school,
residence, social
Not reported TST Not reported Guatemala, Mexico 82
Lowther
2011
Minnesota (rural) Workplace, school,
residence, social
2008 TST El Salvador, Guatemala,
Honduras, Mexico
Guatemala; United
States
150
Person
2010
Wake County, North
Carolina (urban)
Workplace 2005 or later IGRA or
TST
Not reported Not reported 70
Smithee
2011
Oklahoma (not
reported)
Workplace 2010 TST Mexico (most) Not reported 104
Wang
2010
Franklin County,
Ohio (urban)
Workplace, school,
residence, social
contacts
Not reported, index
cases diagnosed in
2006
IGRA or
TST
Not reported West Africa; Kenya 20
https://doi.org/10.1371/journal.pone.0200485.t001
Table 2. Characteristics of TB contact investigations among foreign-born populations in the United States: Majority (50%-90%) foreign-born study populations.
Study Setting (density) Types of contacts Period Test type
used
Contact countries or
regions of origin (non-
USA)
Index case countries or
regions of origin
Number valid
results
Miramontes
2010
Tennessee (not
reported)
Workplace, residence,
social contacts
2007–
2009
TST Guatemala Guatemala 222
Rogers 2011 Greensboro, North
Carolina (urban)
Workplace, school,
residence, social contacts
2010 TST Liberia Not reported 89
Schack 2005 Colorado (rural) Workplace, residence,
social contacts
2004 TST Not reported Uganda 321
Trieu 2013 New York City, New
York (urban)
Workplace, residence 2010–
2011
IGRA Not reported Burma, Tibet 50
Yu 2011 Washington; Hawaii
(both urban)
Residence Not
reported
IGRA or
TST
Micronesia Not reported 18
https://doi.org/10.1371/journal.pone.0200485.t002
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admissibility of proportion values of zero and one. Because TST and IGRA have different sen-
sitivities and specificities, particularly in persons who have received the BCG vaccine, we cal-
culated the following proportions stratified by test-type: positive tests of valid test results,
diagnoses of TB disease of positive tests, and LTBI diagnoses of positive tests.
We also calculated pooled cumulative proportions for each step on the cascade, with the
exception of active tuberculosis diagnoses, which we considered to be a “dead end” state
because of very limited reporting of treatment data for those with active tuberculosis. Cumula-
tive proportions were products of adjacent-step pooled proportions. Detailed methods for cal-
culation of cumulative proportions have been described elsewhere [7].
Risk of bias
We were unable to identify any appropriate tools for the assessment of the risk of bias or meth-
odological quality in the individual studies. Existing standard instruments for assessing bias in
intervention efficacy, prevalence, and other epidemiologic studies are not applicable to studies
reporting the yield of screening programs [9, 10].
Results
Identified studies
The original search in March of 2015 yielded a total of 1,365 peer-reviewed citations and 159
grey literature reports (Fig 1), we identified 22 publications and conference abstracts that met
our eligibility criteria. The search update in April of 2018 yielded 155 peer-reviewed citations,
six of which were reviewed at the full text level. None of these were deemed eligible for inclu-
sion. Because some article databases only allow date restriction by year, some studies published
in early 2015 may have appeared in both searches. Descriptions of the included studies can be
found in Tables 1–3. Studies described contact investigations in 16 different U.S. states (one
did not identify the state), were published or presented between 1986 and 2014, and describe
investigations conducted between 1982 and 2011. Foreign-born populations of contacts were
diverse in national origin. Five [11–15] were aggregate reports of many contact investigations.
Identified contacts fell into three categories: household, workplace/school, and social con-
tacts. The majority (13) of the studies were conducted at multiple sites and included contacts
of more than one nature (e.g. colleagues, peers, familial) with variation in the hours of
Table 3. Characteristics of TB contact investigations among foreign-born populations in the United States: Both majority and predominantly foreign-born study
populations.
Study Setting (density) Types of contacts Period Test
type
used
Contact countries or
regions of origin
(non-USA)
Index case
countries or
regions of origin
Number
valid results
Anger 2012 New York City, New York (urban) Not reported 1997–2003 TST Not reported Many countries 25,164
Golub 2006 Maryland and other states in the
region (not reported)
Workplace, school,
residence, social
contacts
Not reported; index
cases diagnosed
2000–2001
TST Many countries Many countries 136
Grinsdale
2011
San Francisco, California (urban) Workplace, school,
residence, social
contacts
Not reported; index
cases diagnosed
2005–2007
IGRA or
TST
Not reported Many countries 1291
Marks,
2000
California, Georgia, Illinois, New
Jersey, New York, Tennessee,
Texas, Washington (all urban)
Not reported 1996–1997 TST Not reported Not reported 721
Ridzon,
1997
Southern California (not reported) Workplace, school 1993–1994 TST Vietnam Mexico 1,109
https://doi.org/10.1371/journal.pone.0200485.t003
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exposure with the index case. Nine studies were conducted among a single type of contact: six
were workplace or school-based [16–21], two were residence-based [22, 23], and one included
only social contacts [24]. Seven studies included contacts from all three categories [13–15, 18,
25]. All but one study reported the type of contacts [11].
Author contacts
We did not identify any additional studies via author contact, however, one author provided
additional unpublished data [26].
Meta-analysis results
Among PFB populations in studies reporting numbers of persons identified and recruited,
98.8% (95% CI 94.7 to 100.0%) of identified contacts were recruited and 98.9% (95% CI 96.5 to
100.0%) of those recruited had valid test results. Proportions retained in these two steps were
lower for studies in MFB populations; for the two studies reporting numbers identified and
numbers recruited 78.4% (95% CI 78.0% to78.9%) of those identified were recruited and
92.0% (95% CI 91.6 to 92.3%) of those recruited had valid test results. Proportion testing posi-
tive of those with valid results was 54.8% (95% CI 45.3 to 64.1%) for PFB populations and
38.0% (95% CI 31.9 to 44.8%) for MFB populations. The vast majority of persons who tested
positive were diagnosed with LTBI in both PFB and MFB populations Among studies report-
ing the number of active TB cases identified via LTBI testing, 5.5 percent (95% CI 1.2 to 11.7)
of persons in PFB populations testing positive and 3.6% (95% CI 1.6 to 6.0%) of persons in
MFB populations testing positive were diagnosed with TB disease. Treatment outcomes for
persons with TB disease were rarely reported. Heterogeneity varied widely among the various
proportions in the meta-analysis, but was generally high.
Fig 2 shows forest plots for the proportion testing positive of those with valid results and
the proportion diagnosed with LTBI and TB disease of those testing positive, stratified by test
type. For PFB populations, proportion testing positive was lower with IGRA than with TST
(38.1% vs. 60.4%, P for difference 0.02), but for MFB populations, the point estimate of pro-
portion testing positive by test type was similar (35.1% vs. 41.2%), but the confidence interval
for IGRA testing was very wide (12.8% to 72.9%), meaning that substantial differences in pro-
portion may be undetectable. The proportion ultimately diagnosed with TB disease among
those testing positive was lower among those tested with IGRA (1.0% vs. 9.2% for TST) for
PFB populations and higher among those tested with IGRA (5.8% vs. 2.0% for TST) for MFB
populations, but neither difference was significant at α = 0.05. For PFB populations, the pro-
portion diagnosed with LTBI of those with positive tests appeared similar across test types
(although the confidence interval for those tested with IGRA was wide). Among MFB studies,
the single study that used IGRA for testing and also reported the number diagnosed with LTBI
found a lower proportion of LTBI diagnoses than the pooled proportion for MFB studies
using TST.
Adjacent step and cumulative proportions of those reaching each step in the testing and
treatment cascade from identified contacts are shown in Fig 3. For every 1,000 contacts identi-
fied in PFB populations, we estimate that 535 (95% CI 437 to 625) will test positive, 505 (95%
CI 405 to 596) will be diagnosed with LTBI, and 354 (95% CI 244 to 453) will complete LTBI
treatment. For every 1,000 contacts in MFB populations we expect that 276 (95% CI 230 to
Fig 1. Identification and screening of citations: Semi-systematic review of contact investigation TB testing and treatment programs among foreign-born
populations in the US.
https://doi.org/10.1371/journal.pone.0200485.g001
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318), 213 (95% CI 173 to 250), and 134 (95% CI 44 to 264) will test positive, be diagnosed with
LTBI, and complete LTBI treatment, respectively. The lower yield among MFB populations is
due to a combination of lower recruitment rates, lower probability of testing positive, and
lower retention in treatment among those diagnosed with LTBI and offered treatment. Among
PFB, 70.1% (95% CI 52.1 to 84.2%) of those diagnosed with LTBI will complete LTBI treat-
ment. Among MFB groups, 82.1% (95% CI 76.3 to 87.3%) of those testing positive will start
LTBI treatment, but only 52.1% (95% CI 38.1 to 66.0%) of those diagnosed with LTBI will
complete treatment. Looking only at use of TST among PFB populations, out of every 1,000
identified we estimate that the number testing positive, diagnosed with LTBI, and completing
LTBI treatment will be 590 (95% CI 477 to 690), 557 (95% CI 439 to 657), and 390 (95% CI 266
to 489), while among those tested with IGRA, these numbers will be 371 (95% CI 233 to 517),
350 (95% CI 218 to 489), and 255 (95% CI 140 to 359), respectively. Because the proportion
testing positive was similar for TST and IGRA among MFB populations, proportions were
similar for all cumulative cascade proportions.
Discussion
Our findings suggest that contact investigations conducted among mostly foreign-born popu-
lations yield a high proportion of detected infections and treatment completions per contact
identified. This is particularly true for PFB populations, where patient cooperation rates with
testing are in excess of 90% and the majority of identified contacts test positive.
Fig 2. Forest plots for selected cascade proportions by test type and percent foreign-born.
https://doi.org/10.1371/journal.pone.0200485.g002
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In our previous work, we examined the yield of community-based testing programs target-
ing foreign-born persons who were not known to be contacts of infectious TB cases [7]. In that
work, we found that, for every 100 persons targeted in PFB groups, 40 had valid test results, 16
tested positive, and 5 completed LTBI treatment. For MFB groups, these numbers were 80, 26,
and 5, respectively. In this review, we found higher participation among those approached for
testing, better retention through collection of valid test results, higher prevalence of positive
tests, and higher proportions offered LTBI treatment. The higher proportion recruited and
completing treatment may be because recent contacts of infectious cases are more motivated
to cooperate with testing, because of more intensive efforts from contact investigation program
Fig 3. Cumulative proportion of participants retained in testing and treatment cascade in TB contact investigations in the
United States, by percent foreign born and test type.
https://doi.org/10.1371/journal.pone.0200485.g003
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staff, or both. Neither TST nor IGRA is able to distinguish between recent and remote infec-
tion, so for contacts diagnosed with LTBI, it is impossible to know whether they were actually
infected by the contact investigation index case. Therefore, it is not clear whether TB infection
prevalence is higher in this study because of transmission from the index case, or because con-
tact investigations are better at targeting persons who are already at high risk of infection. It is
also not clear why persons in contact investigations seem to be more likely to be offered treat-
ment, but it may be due to the involvement of health department TB clinics, where treatment
can be offered and followed up by knowledgeable staff.
There are a number of limitations of this study. Because of the lack of well accepted and
widely used bias assessment tools for the type of studies in this review, we did not conduct a
formal bias assessment. However, we can speculate on the types of biases that may have
affected our results. Because contact investigations are conducted as public health operations
rather than research, and public health practitioners are often too busy to write journal articles,
there is publication bias in articles of contact investigation. While a recent CDC publication
on routinely collected contact investigation indicators over a decade includes the care contin-
uum steps included in this analysis, the indicators were not divided by US born and foreign-
born contacts, so we have no way of assessing how published or presented results of investiga-
tions of foreign-born persons differ from those whose findings are never disseminated as pub-
lished articles. Our estimates of the proportion of identified contacts diagnosed with LTBI
(50.5% for PFB, 25.7% for MFB) are higher than the 20.5% diagnosed with LTBI among all
722,403 contacts evaluated and reported by 44 states and Puerto Rico to the CDC between
2003 and 2012 [27]. The differences are likely due to lower LTBI prevalence among US-born
contacts, or to reporting or other bias in our estimates. The CDC report found a 46% rate of
treatment completion among those diagnosed with LTBI that was similar to our 52% comple-
tion rate for MFB populations, but lower than the 70% seen for PFB. Misclassification is partic-
ularly problematic for data in the latter two steps in the cascade, number starting and
completing treatment. Because directly observed therapy is generally recommended only for
persons at high risk of default, most programs used self-administered therapy for LTBI treat-
ment, and may have relied on self-report of initiation and completion of treatment, or used
other proxies such as number of prescriptions filled. Also, persons may have been considered
lost to follow-up if they left the country during treatment, even if they continued treatment
abroad. Most studies did not provide adequate information about data collection practices to
properly assess risk of misclassification. Interpretation of the proportion testing positive as the
actual prevalence of tuberculosis infection should be done with caution, particularly for studies
that used TST rather than IGRA, as sensitivity and specificity are imperfect and differ by test.
We found high heterogeneity in many of many of our proportions. The random effects
model used to calculate the pooled proportions explicitly allows for heterogeneity of effect
measure between studies. However, high heterogeneity indicates that the proportions proceed-
ing from one cascade step to another are likely to vary widely between programs. Program
planners, modelers, and others who may wish to use our results should consider the confi-
dence intervals, which take heterogeneity into account, along with the pooled proportions.
Our intention was to examine testing for TB infection of adults and adolescents. However,
some studies included children, and did not report results for children and adults separately.
In those cases, the study groups included in the meta-analysis contain a small number of chil-
dren. This is important because LTBI testing in children gives unreliable results, either because
of false positivity due to infection with non-tuberculous mycobacteria or due to non-reactions
because of developing immune systems in very young children. In addition, since TB infection
identified through positive reactions to TST or IGRA, could indicate either TB disease or
LTBI, we included both testing positive and LTBI diagnosis as steps in the cascade. We feel
Yield of TB contact investigation in foreign-born populations in the USA
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that this approach shows readers the difference between a positive test and LTBI diagnosis,
both due to a small number of persons with TB disease and because some people do not com-
plete follow-up evaluation to rule out TB disease.
Data collection for the investigations included in this review dated back to 1993, which
leads to limited generalizability to future contact investigation outputs, given changes over
time in both the prevalence of TB infection in the US and the technology available for TB
testing and treatment. Of note, the majority of the studies we identified used TST, rather
than IGRA, for testing. In part, this is because IGRA is a newer technology, with first gener-
ation tests first licensed in 2001, and more specific second generation tests first licensed in
2005. However, even among the thirteen studies reporting investigations known or sus-
pected to be conducted after 2005, five wholly relied on TST rather than IGRA and four
used a combination of TST and IGRA. If IGRA eventually becomes the standard test for
investigation of foreign born contacts, the proportion of persons testing positive of those
with valid results will likely be lower than estimated here, but persons testing positive will
also be more likely to be truly infected, lowering the number needed to treat to prevent one
case of active TB. Also, no studies were published in 2012 or later. This is important because
the US Centers for Disease Control and Prevention issued guidelines in December of 2011
for use of a 12-dose, 3-month combined isoniazid and rifapentine treatment regimen
(known as 3HP) provided by directly observed therapy, which has been documented to
have greater completion rates (~80%) than longer (6 to 9 month) isoniazid treatment regi-
mens [28]. As 3HP becomes the standard of care for LTBI treatment, this study documents
historical treatment completion for comparison.
Conclusions
Contact investigations appear to be an effective means of recruiting FB persons for targeted
TB testing and treatment. However, while there are only a few thousand cases of active TB per
year in the US, there are millions of persons with LTBI living in the United States, most of
whom were infected abroad. Contact investigations alone clearly cannot be relied upon to
reach the majority of at-risk foreign-born persons, and must be supplemented with other tar-
geted testing activities, such as community-based targeted testing programs and pre-arrival
testing and treatment of US-bound immigrants [7, 29], if sustained declines in tuberculosis
incidence and prevalence are to be achieved.
Supporting information
S1 File. Database search strategies.
(DOCX)
S2 File. Data extraction sheet.
(CSV)
S3 File. Articles screened at the full-text level.
(DOCX)
S4 File. Proportion and 95% confidence interval for TB testing and treatment cascade.
(DOCX)
S5 File. Prisma checklist.
(DOCX)
Yield of TB contact investigation in foreign-born populations in the USA
PLOS ONE | https://doi.org/10.1371/journal.pone.0200485 July 19, 2018 11 / 13
Author Contributions
Conceptualization: Mohsen Malekinejad, Suzanne M. Marks, James G. Kahn.
Data curation: Amanda P. Miller.
Formal analysis: Andrea Parriott.
Funding acquisition: James G. Kahn.
Investigation: Andrea Parriott, Mohsen Malekinejad, James G. Kahn.
Methodology: Andrea Parriott, Hacsi Horvath.
Writing – original draft: Andrea Parriott, Mohsen Malekinejad, Amanda P. Miller, Hacsi
Horvath.
Writing – review & editing: Andrea Parriott, Mohsen Malekinejad, Amanda P. Miller, Hacsi
Horvath, Suzanne M. Marks, James G. Kahn.
References
1. Centers for Disease Control and Prevention. Reported Tuberculosis in the United States, 2015. Atlanta,
GA: Services United States Department of Health and Human Services; 2016.
2. Miramontes R, Hill AN, Yelk Woodruff RS, Lambert LA, Navin TR, Castro KG, et al. Tuberculosis Infec-
tion in the United States: Prevalence Estimates from the National Health and Nutrition Examination Sur-
vey, 2011–2012. PloS one. 2015; 10(11):e0140881. https://doi.org/10.1371/journal.pone.0140881
PMID: 26536035; PubMed Central PMCID: PMC4633161.
3. Davidow AL, Katz D, Ghosh S, Blumberg H, Tamhane A, Sevilla A, et al. Preventing Infectious Pulmo-
nary Tuberculosis Among Foreign-Born Residents of the United States. Am J Public Health. 2015; 105
(9):e81–8. https://doi.org/10.2105/AJPH.2015.302662 PMID: 26180947; PubMed Central PMCID:
PMC4539796.
4. Liu Y, Painter JA, Posey DL, Cain KP, Weinberg MS, Maloney SA, et al. Estimating the impact of newly
arrived foreign-born persons on tuberculosis in the United States. PloS one. 2012; 7(2):e32158. https://
doi.org/10.1371/journal.pone.0032158 PMID: 22384165; PubMed Central PMCID: PMC3287989.
5. Mazurek GH, Jereb J, Vernon A, LoBue P, Goldberg S, Castro K, et al. Updated guidelines for using
Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection—United States,
2010. MMWR Recommendations and reports: MMWR Recomm Rep. 2010; 59(RR-5):1–25. PMID:
20577159.
6. Centers for Disease Control and Prevention. Division of Tuberculosis Elimination Strategic Plan 2016–
2020 2015 [updated November 24, 2015; cited 7/19/2017]. Available from: https://www.cdc.gov/tb/
about/strategicplan.htm.
7. Malekinejad M, Parriott A, Viitanen A, Horvath H, Marks S, Kahn J. Yield of community-based tuberculo-
sis targeted testing and treatment in foreign-born populations in the United States: A systematic review.
PloS one. 2017; 12: e0180707. https://doi.org/10.1371/journal.pone.0180707 PMID: 28786991
8. Higgins J, Green S. Cochrane Handbook for Systematic Reviews of Interventions. 5.1.0 ed: The
Cochran Collaboration; 2011.
9. Higgins JP, Altman DG, Sterne JA. Assessing risk of bias in included studies. In: Higgins J, Green S,
editors. Cochrane Handbook for Systematic Reviews of Interventions Version 510: The Cochrane Col-
laboration; 2011.
10. Hoy D, Brooks P, Woolf A, Blyth F, March L, Bain C, et al. Assessing risk of bias in prevalence studies:
modification of an existing tool and evidence of interrater agreement. J Clin Epidemiol. 2012; 65
(9):934–9. https://doi.org/10.1016/j.jclinepi.2011.11.014 PMID: 22742910.
11. Anger HA, Proops D, Harris TG, Li J, Kreiswirth BN, Shashkina E, et al. Active case finding and preven-
tion of tuberculosis among a cohort of contacts exposed to infectious tuberculosis cases in New York
City. Clin Infect Dis. 2012; 54(9):1287–95. https://doi.org/10.1093/cid/cis029 PMID: 22412056.
12. Driver CR, Balcewicz-Sablinska MK, Kim Z, Scholten J, Munsiff SS. Contact investigations in congre-
gate settings, New York City. Int J Tuberc Lung Dis. 2003; 7(12 Suppl 3):S432–8. PMID: 14677834.
13. Golub JE, Bur S, Cronin WA, Gange S, Baruch N, Comstock GW, et al. Delayed tuberculosis diagnosis
and tuberculosis transmission. Int J Tuberc Lung Dis. 2006; 10(1):24–30. Epub 2006/02/10. PMID:
16466033.
Yield of TB contact investigation in foreign-born populations in the USA
PLOS ONE | https://doi.org/10.1371/journal.pone.0200485 July 19, 2018 12 / 13
14. Grinsdale JA, Ho CS, Banouvong H, Kawamura LM. Programmatic impact of using QuantiFERON(R)-
TB Gold in routine contact investigation activities. Int J Tuberc Lung Dis. 2011; 15(12):1614–20. Epub
2011/11/29. https://doi.org/10.5588/ijtld.11.0102 PMID: 22118167.
15. Marks SM, Taylor Z, Qualls NL, Shrestha-Kuwahara RJ, Wilce MA, Nguyen CH. Outcomes of contact
investigations of infectious tuberculosis patients. Am J Respir Crit Care Med. 2000; 162(6):2033–8.
https://doi.org/10.1164/ajrccm.162.6.2004022 PMID: 11112109; PubMed Central PMCID:
PMC5448278.
16. Gulati M, Liss DJ, Sparer JA, Slade MD, Holt EW, Rabinowitz PM. Risk factors for tuberculin skin test
positivity in an industrial workforce results of a contact investigation. J Occup Environ Med. 2005; 47
(11):1190–9. Epub 2005/11/12. PMID: 16282881.
17. Kambali S, Nantsupawat N, Lee M, Nugent K. A Workplace Tuberculosis Case Investigation in the
Presence of Immigrant Contacts from High Prevalence Countries. J Community Health. 2014. Epub
2014/09/23. https://doi.org/10.1007/s10900-014-9946-3 PMID: 25236657.
18. Kim DY, Ridzon R, Giles B, Mireles T. Pseudo-outbreak of tuberculosis in poultry plant workers, Sussex
County, Delaware. J Occup Environ Med. 2002; 44(12):1169–72. https://doi.org/10.1097/00043764-
200212000-00011 PMID: 12500459
19. Person AK, Goswami ND, Bissette DJ, Turner DS, Baker AV, Gadkowski LB, et al. Pairing Quanti-
FERON gold in-tube with opt-out HIV testing in a tuberculosis contact investigation in the Southeastern
United States. Aids Patient Care STDS. 2010; 24(9):539–43. Epub 2010/08/25. https://doi.org/10.1089/
apc.2010.0102 PMID: 20731612; PubMed Central PMCID: PMCPMC2958451.
20. Ridzon R, Kent JH, Valway S, Weismuller P, Maxwell R, Elcock M, et al. Outbreak of drug-resistant
tuberculosis with second-generation transmission in a high school California. J Pediatr. 1997; 131
(6):863–8. PubMed PMID: WOS:000071165100016. PMID: 9427891
21. Smithee L, editor Application of IGRA to a Contact Investigation Involving a Predominant Mexican Pop-
ulation in a Worksite 7th Annual Conference on Laboratory Aspects of Tuberculosis; 2011 Wednesday,
June 15, 2011; Atlanta, Georgia.
22. Ho C. TB Outreach Among Indigenous Mexican Immigrants in San Francisco. TB Notes. 2010;(3):7–
10.
23. Yu DT. Cultural considerations in TB Contact Investigation. National Tuberculosis Controllers Associa-
tion Annual Meeting; Atlanta, GA2011.
24. Albrecht T. A Multi-Jurisdictional TB Outbreak Among Seasonal Agricultural Workers From Oaxaca,
Mexico. TB Notes. 2004;(2):4–6.
25. Lowther SA, Miramontes R, Navara B, Sabuwala N, Brueshaber M, Solarz S, et al. Outbreak of tubercu-
losis among Guatemalan immigrants in rural Minnesota, 2008. Public Health Rep. 2011; 126(5):726–
32. Epub 2011/09/03. https://doi.org/10.1177/003335491112600515 PMID: 21886333; PubMed Cen-
tral PMCID: PMCPMC3151190.
26. Brisette B. Challenges and Innovative Solutions in the Case Management of Immigrant Patients
National Tuberculosis Controllers Association Annual Meeting; Atlanta Georgia2011.
27. Young KH, Ehman M, Reves R, Peterson Maddox BL, Khan A, Chorba TL, et al. Tuberculosis Contact
Investigations—United States, 2003–2012. MMWR Morb Mortal Wkly Rep. 2016; 64(50–51):1369–74.
https://doi.org/10.15585/mmwr.mm6450a1 PMID: 26720627.
28. Centers for Disease Control and Prevention. Recommendations for use of an isoniazid-rifapentine regi-
men with direct observation to treat latent Mycobacterium tuberculosis infection. MMWR Morb Mortal
Wkly Rep. 2011; 60(48):1650–3. PMID: 22157884.
29. Wingate LT, Coleman MS, de la Motte Hurst C, Semple M, Zhou W, Cetron MS, et al. A cost-benefit
analysis of a proposed overseas refugee latent tuberculosis infection screening and treatment program.
BMC public health. 2015; 15:1201. https://doi.org/10.1186/s12889-015-2530-7 PMID: 26627449;
PubMed Central PMCID: PMC4666176.
Yield of TB contact investigation in foreign-born populations in the USA
PLOS ONE | https://doi.org/10.1371/journal.pone.0200485 July 19, 2018 13 / 13
